Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | AXL | P30530 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.39 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.39 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.39 |
| ▸ | CFTR | P13569 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.38 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2264306 | 0.84 | SMN1; SMN2 (0.39) | SMN1; SMN2PDE4DAXLMEN1PSIP1 | |
| SCHEMBL27593798 | 0.80 | KDM4E (0.40) | SMN1; SMN2MEN1SLC6A2SLC6A3GAA | |
| SCHEMBL2494591 | 0.74 | CFTR (0.58) | SMN1; SMN2CFTRSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL27595708 | 0.74 | CYP17A1 (0.42) | SMN1; SMN2PDE4DCFTRSLC6A2SLC6A4 | |
| SCHEMBL7160029 | 0.74 | PDE10A (0.42) | SLC6A4GAAALDH1A1TSHRMAPT | |
| SCHEMBL7117300 | 0.72 | SMN1; SMN2 (0.46) | SMN1; SMN2CFTRSLC6A2SLC6A4SLC6A3 | |
| Hydrochloric Acid SCHEMBL3751857 | 0.72 | CFTR (0.56) | SMN1; SMN2CFTRSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL3977541 | 0.71 | CHRNB4 (0.38) | PDE4DAXLMEN1PSIP1MKNK1 | |
| SCHEMBL5681756 | 0.71 | MEN1 (0.48) | SMN1; SMN2MEN1CFTRGOPCGAA | |
| SCHEMBL4200912 | 0.71 | ADRB1 (0.46) | SMN1; SMN2CFTRSLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1449276-A | Primary intermediates for oxidative dyeing of hair | P & G CLAIROL INC (US) | 2003-10-15 | — | — | CN | claimed |
| EP-1331918-A1 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | Clairol Incorporated (US) | 2003-08-06 | — | — | EP | claimed |
| US-6562080-B2 | 2-arylaminomethyl-4-aminophenols; light fastness, fastness to shampooing, fastness to permanent wave treatment | CLAIROL INCORPORATED | 2003-05-13 | — | — | US | claimed |
| US-20020144355-A1 | Primary intermediates for oxidative coloration of hair | WELLA OPERATIONS US, LLC | 2002-10-10 | — | — | US | claimed |
| WO-2002017866-A1 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | P&G-CLAIROL, INC. (US) | 2002-03-07 | — | — | WO | claimed |
| US-12133906-B2 | Delivery particle | THE PROCTER & GAMBLE COMPANY (US) | 2024-11-05 | — | — | US | disclosed |
| US-20220409497-A1 | DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2022-12-29 | — | — | US | disclosed |
| EP-3733827-A1 | DELIVERY PARTICLES | The Procter & Gamble Company (US) | 2020-11-04 | — | — | EP | disclosed |
| EP-2563508-B1 | DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2019-07-10 | — | — | EP | disclosed |
| EP-1642563-B1 | Method of rapid hair dyeing | NOXELL CORP (US) | 2019-06-26 | — | — | EP | disclosed |
| US-20190142714-A1 | DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2019-05-16 | — | — | US | disclosed |
| EP-1484048-B1 | Hair colouring compositions | NOXELL CORP (US) | 2019-01-02 | — | — | EP | disclosed |
| EP-1331918-A1 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | Clairol Incorporated (US) | 2003-08-06 | — | — | EP | disclosed |
| US-6562080-B2 | 2-arylaminomethyl-4-aminophenols; light fastness, fastness to shampooing, fastness to permanent wave treatment | CLAIROL INCORPORATED | 2003-05-13 | — | — | US | disclosed |
| US-6540793-B1 | Coupler for use in oxidative hair dyeing | CLAIROL INCORPORATED | 2003-04-01 | — | — | US | disclosed |
| CN-1396819-A | Novel couplers for oxidative hair dyeing | P & G CLAROR INC (US) | 2003-02-12 | — | — | CN | disclosed |
| EP-1251822-A1 | NOVEL COUPLER FOR USE IN OXIDATIVE HAIR DYEING | Clairol Incorporated (US) | 2002-10-30 | — | — | EP | disclosed |
| US-20020144355-A1 | Primary intermediates for oxidative coloration of hair | WELLA OPERATIONS US, LLC | 2002-10-10 | — | — | US | disclosed |
| WO-2002017866-A1 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | P&G-CLAIROL, INC. (US) | 2002-03-07 | — | — | WO | disclosed |
| WO-2001056538-A1 | NOVEL COUPLER FOR USE IN OXIDATIVE HAIR DYEING | P&G-CLAIROL, INC. (US) | 2001-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220409497-A1 | DELIVERY PARTICLE | LIPA, CHMP4B, SLC46A1 | SMN1; SMN2 622/4885PDE4D 1157/4885AXL 3974/4885 |
| US-20020144355-A1 | Primary intermediates for oxidative coloration of hair | CYC1, CBR1, CBR3 | SMN1; SMN2 4837/4885PDE4D 3896/4885AXL 3166/4885 |
| US-12133906-B2 | Delivery particle | LIPA, CHMP4B, SLC46A1 | SMN1; SMN2 622/4885PDE4D 1157/4885AXL 3974/4885 |
| US-20190142714-A1 | DELIVERY PARTICLE | LIPA, CHMP4B, SLC46A1 | SMN1; SMN2 622/4885PDE4D 1157/4885AXL 3974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.